Sigma was the defendant in a suit brought by Enzo alleging, among other things, breach of contract and infringement of patents. Terms of the settlement were not disclosed.
The settlement agreement followed the recent Markman Hearing ruling by a Federal Court Judge in the Southern District of New York relating to claim terms in eight patents asserted against Sigma.
“Enzo is pleased to have settled with Sigma-Aldrich on favorable terms. Sigma is the first defendant to settle in the various actions brought by Enzo. We continue to aggressively pursue our claims with respect to the remaining defendants,” said Enzo.
Enzo Biochem is engaged in the research, development and manufacture of innovative health care products based on molecular biology and genetic engineering techniques.